Jeffrey D Balduzzi, MD
Allergy/Immunology · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 14 years
- University of Virginia School of Medicine, 2012
Offices
1 location · Allergy Immunology and Asthma Medical Group Inc · 4 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Balduzzi’s office at (209) 951-5353 to ask if they take your plan before you enroll.
California Medical Board record
Licence A173115 · Current
Licensed to practise in California · since 2021 · expires 2027-06-30 · University of Virginia School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Allergy and Immunology - Allergy and Immunology
- American Board of Internal Medicine - Internal Medicine
Original Medicare doctor bills
$202,903
Medicare paid this office $202,903 for 254 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 14 | $8,314 | $60 |
| Professional service for preparation and provision of 1 or more antigens | 25 | $7,759 | $12 |
| Short return visit (20+ min) | 66 | $6,835 | $70 |
| Return visit (30+ min) | 33 | $5,788 | $102 |
| Test for allergy using allergenic extract | 40 | $5,645 | $3 |
See all 14 services
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 14 | $8,314 | $60 |
| Professional service for preparation and provision of 1 or more antigens | 25 | $7,759 | $12 |
| Short return visit (20+ min) | 66 | $6,835 | $70 |
| Return visit (30+ min) | 33 | $5,788 | $102 |
| Test for allergy using allergenic extract | 40 | $5,645 | $3 |
| New patient visit (45+ min) | 46 | $5,541 | $120 |
| Test for allergy using allergenic extract injected into skin | 28 | $5,511 | $7 |
| Professional service for multiple injections of allergen | 147 | $5,036 | $9 |
| Short return visit | 16 | $4,647 | $45 |
| New patient visit (30+ min) | 21 | $1,385 | $66 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $933 | $72 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 12 | $423 | $30 |
| Test to measure expiratory airflow and volume | 14 | $363 | $21 |
| Professional service for single injection of allergen | 15 | $165 | $8 |
Who their Medicare patients are
254 Original Medicare patients in 2024. Average age 71 · Under 65 13% · 85 and older 6% · Women 69% · Also on Medicaid 34% · Health risk score 1.09. Above the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 74% · Diabetes 32% · COPD 24% · Coronary heart disease 23% · Chronic kidney disease 23% · Depression 19% · Heart failure 16% · Atrial fibrillation 14% · Cancer 10% · Stroke 7%.
The office billed $387,636, Medicare allowed $258,250 and paid $202,903; for 13,237 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 254 | 13,237 | 71 | 1.09 | $387,636 | $202,903 |
| 2023 | 105 | 5,183 | 71 | 0.96 | $140,431 | $75,632 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Test for allergy using allergenic extract | 24 | $4,212 | $3 |
| Return visit (30+ min) | 33 | $3,637 | $96 |
| Short return visit (20+ min) | 43 | $3,528 | $71 |
| Test for allergy using allergenic extract injected into skin | 15 | $3,273 | $7 |
| New patient visit (45+ min) | 24 | $3,017 | $126 |
| New patient visit (30+ min) | 21 | $1,905 | $91 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $924 | $71 |
| Test to measure expiratory airflow and volume | 18 | $403 | $21 |
Medicaid work
$275,968 in 2024
Medicaid paid $275,968 for 5,267 billed services this clinician did in 2024, up to 281 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 468 | $61,046 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 418 | $52,712 |
| ANTIGEN THERAPY SERVICES | 143 | $48,971 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 2,774 | $33,853 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 231 | $23,913 |
| Return visit (30+ min) | 339 | $18,967 |
| Short return visit (20+ min) | 517 | $18,522 |
| New patient visit (45+ min) | 90 | $8,894 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 185 | $6,346 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 12 | $1,134 |
| EVALUATION OF WHEEZING | 12 | $811 |
| IMMUNOTHERAPY ONE INJECTION | 66 | $470 |
| 2024 | 5,267 | 13 | 281 | $275,968 |
| 2023 | 1,118 | 7 | 38 | $69,410 |
| 2022 | 106 | 2 | 19 | $237 |
See the largest Medicaid services in earlier years
2023
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 188 | $24,404 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 171 | $21,958 |
| Short return visit (20+ min) | 210 | $7,769 |
| Return visit (30+ min) | 123 | $5,270 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 324 | $4,053 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 40 | $3,797 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 62 | $2,158 |
2022
| Return visit (30+ min) | 80 | $143 |
| New patient visit (45+ min) | 26 | $94 |
Drugs they prescribed that Part D paid
$56,889
Pharmacies billed $56,889 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 23) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
0 generic and 18 brand-name prescriptions · $56,889 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 23 | None | 0% (0) | 78% | $56,889 |
| 2023 | 100 | 25 | 0% (0) | 35% | $96,466 |
| 2022 | 111 | 38 | 0% (0) | 26% | $32,979 |
| 2021 | 384 | 82 | 0% (0) | 34% | $978,377 |
| 2020 | 260 | 71 | 0% (0) | 47% | $176,972 |
| 2019 | 90 | 32 | 0% (0) | None | $5,465 |
| 2018 | 49 | 22 | None | None | $1,094 |
| 2017 | 144 | 45 | None | None | $7,940 |
| 2016 | 70 | 38 | None | None | $1,623 |
| 2015 | 19 | None | 0% (0) | None | $978 |
| 2014 | 34 | None | 0% (0) | None | $1,322 |
| 2013 | 25 | None | 0% (0) | None | $2,236 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Xolair | 19 | $82,239 | $4,328 |
| Trelegy Ellipta | 11 | $9,104 | $828 |
| Ipratropium | 12 | $481 | $40 |
| Azelastine | 12 | $394 | $33 |
2022: 3 drugs
| Ipratropium | 16 | $869 | $54 |
| Azelastine | 16 | $708 | $44 |
| Montelukast | 13 | $172 | $13 |
2021: 12 drugs
| Icatibant | None | 13 | $614,566 | $47,274 |
| Hizentra | Immune globulin | 27 | $144,983 | $5,370 |
| Fasenra | None | 13 | $71,859 | $5,528 |
| Xolair | None | 29 | $70,105 | $2,417 |
| Advair Hfa | None | 16 | $7,596 | $475 |
| Cyclosporine Modified | None | 16 | $1,977 | $124 |
| Ipratropium | None | 39 | $1,739 | $45 |
| Dapsone | None | 11 | $1,013 | $92 |
| Gabapentin | None | 12 | $598 | $50 |
| Azelastine | None | 17 | $554 | $33 |
| Fluticasone Propionate | None | 31 | $398 | $13 |
| Montelukast | None | 46 | $347 | $8 |
2020: 9 drugs
| Hizentra | Immune globulin | 25 | $76,303 | $3,052 |
| Symbicort | None | 16 | $8,269 | $517 |
| Breo Ellipta | None | 16 | $5,932 | $371 |
| Epinephrine | None | 12 | $3,156 | $263 |
| Ipratropium | None | 38 | $2,374 | $62 |
| Fluticasone Propionate | None | 15 | $307 | $20 |
| Famotidine | None | 12 | $281 | $23 |
| Montelukast | None | 18 | $151 | $8 |
| Prednisone | None | 14 | $46 | $3 |
2017: 1 drug
| Atorvastatin | 11 | $112 | $10 |
Money from drug and device companies
$1,485 in 2025
| 2025 | 18 | 93 | None | $1,485 |
| 2024 | 13 | 61 | None | $946 |
| 2023 | 17 | 99 | None | $1,766 |
| 2022 | 23 | 77 | None | $1,428 |
| 2021 | 10 | 28 | None | $651 |
| 2020 | 1 | 2 | None | $208 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Fasenra | $253 | 7 payments
|
| Genzyme | Dupixent | $212 | 14 payments
|
| Regeneron Healthcare Solutions | Dupixent | $204 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $137 | 7 payments
|
| CSL Behring | Hizentra | $98 | 6 payments
|
| Grifols USA | Prolastin-C Liquid | $90 | 4 payments
|
See all 71 published payments
| Genzyme | Meals · 2025-12-16 | Dupixent | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-12-15 | Dupixent | $34 |
| Regeneron Healthcare Solutions | Meals · 2025-12-09 | Dupixent | $28 |
| Amgen | Meals · 2025-12-01 | Tezspire | $15 |
| Novartis Pharmaceuticals | Meals · 2025-11-18 | Xolair | $21 |
| Baxter Healthcare | Meals · 2025-11-12 | Hillrom - Monarch Airway Clearance System | $22 |
| Galderma Laboratories L.P. | Meals · 2025-11-06 | Nemluvio | $14 |
| Genzyme | Meals · 2025-11-05 | Dupixent | $5 |
| Organon | Meals · 2025-10-29 | Vtama | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-22 | Cuvitru | $17 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-17 | Cuvitru | $23 |
| Genzyme | Meals · 2025-10-15 | Dupixent | $8 |
| BioCryst US Sales Co. | Meals · 2025-10-14 | Orladeyo | $26 |
| Organon | Meals · 2025-10-02 | Vtama | $4 |
| CSL Behring | Meals · 2025-10-01 | Hizentra | $17 |
| GlaxoSmithKline | Meals · 2025-09-25 | Nucala | $19 |
| Genzyme | Meals · 2025-09-23 | Dupixent | $26 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-16 | Cuvitru | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-09-15 | Dupixent | $29 |
| Amgen | Meals · 2025-09-15 | Tezspire | $18 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-11 | Eohilia | $12 |
| Grifols USA | Meals · 2025-09-11 | Prolastin-C Liquid | $24 |
| CSL Behring | Meals · 2025-09-02 | Andembry | $18 |
| Incyte | Meals · 2025-08-29 | Opzelura | $14 |
| Genzyme | Meals · 2025-08-20 | Dupixent | $7 |
| Novartis Pharmaceuticals | Meals · 2025-08-12 | None | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-08-04 | Dupixent | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-23 | Tezspire | $18 |
| BioCryst US Sales Co. | Meals · 2025-07-10 | Orladeyo | $23 |
| CSL Behring | Meals · 2025-07-09 | Andembry | $14 |
| Genzyme | Meals · 2025-07-07 | Dupixent | $9 |
| CSL Behring | Meals · 2025-06-25 | Hizentra | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-06-24 | Dupixent | $35 |
| Genzyme | Meals · 2025-06-23 | Dupixent | $19 |
| Genzyme | Meals · 2025-06-13 | Dupixent | $22 |
| Kowa Pharmaceuticals America | Meals · 2025-06-11 | Zoryve | $20 |
| Baxter Healthcare | Meals · 2025-05-30 | Hillrom - Monarch Airway Clearance System | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-29 | Airsupra | $20 |
| Grifols USA | Meals · 2025-05-29 | Prolastin-C Liquid | $20 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-28 | Cuvitru | $15 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-19 | Cuvitru | $24 |
| Grifols USA | Meals · 2025-05-08 | Xembify | $20 |
| Novartis Pharmaceuticals | Meals · 2025-05-06 | None | $30 |
| Genzyme | Meals · 2025-05-06 | Dupixent | $8 |
| CSL Behring | Meals · 2025-04-30 | Haegarda | $18 |
| Optinose US | Meals · 2025-04-22 | Xhance | $15 |
| ARS Pharmaceuticals Operations | Meals · 2025-04-22 | Neffy | $28 |
| Genzyme | Education · 2025-04-18 | Dupixent | $8 |
| Genzyme | Meals · 2025-04-18 | Dupixent | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-04-08 | Dupixent | $23 |
| Amgen | Meals · 2025-04-07 | Tezspire | $18 |
| Amgen | Meals · 2025-04-01 | Tezspire | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-27 | Fasenra | $22 |
| Grifols USA | Meals · 2025-03-25 | Prolastin-C Liquid | $27 |
| Incyte | Meals · 2025-03-22 | Opzelura | $15 |
| Optinose US | Meals · 2025-03-19 | Xhance | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-03-19 | Dupixent | $28 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-12 | Cuvitru | $18 |
| Genzyme | Meals · 2025-03-11 | Dupixent | $21 |
| Genzyme | Meals · 2025-03-06 | Dupixent | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-04 | Tezspire | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-27 | Fasenra | $16 |
| Amgen | Meals · 2025-02-12 | Tezspire | $14 |
| Pfizer | Education · 2025-02-05 | Cibinqo | $15 |
| Pfizer | Meals · 2025-02-05 | Cibinqo | $25 |
| Genzyme | Meals · 2025-02-04 | Dupixent | $24 |
| CSL Behring | Meals · 2025-01-23 | Hizentra | $15 |
| Optinose US | Meals · 2025-01-21 | Xhance | $24 |
| GlaxoSmithKline | Meals · 2025-01-21 | Trelegy Ellipta | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-11 | Fasenra | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-09 | Fasenra | $143 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $946
| Genzyme | Dupixent | $178 | 15 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $166 | 5 payments
|
| CSL Behring | Haegarda | $145 | 9 payments
|
| Regeneron Healthcare Solutions | Dupixent | $112 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $62 | 3 payments
|
| Amgen | Tezspire | $57 | 3 payments
|
| Novartis Pharmaceuticals | Xolair | $43 | 2 payments
|
| Octapharma USA | Cutaquig | $43 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $43 | 2 payments
|
| Grifols USA | Xembify | $28 | 1 payment
|
| Incyte | Opzelura | $25 | 1 payment
|
| Optinose US | Xhance | $24 | 1 payment
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $20 | 1 payment
|
2023: $1,766
| Regeneron Healthcare Solutions | Dupixent | $219 | 7 payments
|
| Grifols USA | Xembify | $199 | 9 payments
|
| GlaxoSmithKline | Nucala | $198 | 18 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $176 | 9 payments
|
| Pfizer | Eucrisa | $173 | 13 payments
|
| Genzyme | Dupixent | $134 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $133 | 5 payments
|
| Amgen | Tezspire | $96 | 4 payments
|
| CSL Behring | Hizentra | $81 | 4 payments
|
| Novartis Pharmaceuticals | Xolair | $75 | 4 payments
|
| Genentech USA | Xolair | $62 | 2 payments
|
| kaleo | Auvi-Q | $60 | 2 payments
|
| BioCryst US Sales Co. | Orladeyo | $58 | 3 payments
|
| Optinose US | Xhance | $30 | 2 payments
|
| LEO Pharma | Adbry | $25 | 1 payment
|
| Merck Sharp & Dohme | None | $23 | 1 payment
|
| Octapharma USA | Cutaquig | $22 | 1 payment
|
2022: $1,428
| Amgen | Tezspire | $163 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $152 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $122 | 6 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $120 | 12 payments
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $119 | 3 payments
|
| kaleo | Auvi-Q | $88 | 4 payments
|
| BioCryst US Sales Co. | Orladeyo | $76 | 4 payments
|
| Chiesi USA | Bethkis | $70 | 2 payments
|
| Genentech USA | Xolair | $67 | 2 payments
|
| Grifols USA | Xembify | $61 | 3 payments
|
| Pfizer | Octagam Immune Globulin (Human) | $53 | 2 payments
|
| CSL Behring | Haegarda | $43 | 3 payments
|
| OptiNose US | Xhance | $42 | 2 payments
|
| Pharming Healthcare | Ruconest | $39 | 2 payments
|
| Abbvie | Rinvoq | $34 | 2 payments
|
| Electromed | Smartvest | $32 | 1 payment
|
| Genzyme | Dupixent | $27 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $25 | 1 payment
|
| ADMA BioManufacturing | None | $25 | 2 payments
|
| Aimmune Therapeutics | Palforzia | $20 | 1 payment
|
| LEO Pharma | Adbry | $18 | 1 payment
|
| Incyte | Opzelura | $16 | 1 payment
|
| Covis Pharma GmBH | Alvesco | $15 | 1 payment
|
2021: $651
| Genzyme | Dupixent | $211 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $81 | 3 payments
|
| kaleo | Auvi-Q | $66 | 3 payments
|
| CSL Behring | Haegarda | $62 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $54 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $52 | 2 payments
|
| BioCryst US Sales Co. | Orladeyo | $47 | 3 payments
|
| GlaxoSmithKline | Nucala | $41 | 2 payments
|
| Amgen | None | $25 | 1 payment
|
| Incyte | Opzelura | $13 | 1 payment
|
2020: $208
| AstraZeneca Pharmaceuticals LP | Fasenra | $208 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1235405952
- Licence
- CA A173115California A173115: Current · expires 2027-06-30
- Trained
- University of Virginia School of Medicine, 2012 · 14 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207KA0200X (207KA0200X)
- Mailing address
- 4628 Georgetown Pl, Stockton, CA, 95207
- NPI first listed
- 2012-03-27
- NPI last updated
- 2022-02-04
- NPI record certified
- 2022-02-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5609 J St Ste C, Sacramento, CA, 95819